Topotecan liposomal - Spectrum Pharmaceuticals

Drug Profile

Topotecan liposomal - Spectrum Pharmaceuticals

Alternative Names: Brakiva; INX-0076; Liposomal topotecan; Optisomal topotecan; Sphingosome-encapsulated topotecan; Topotecan liposome injection; Topotecan-TCS

Latest Information Update: 18 May 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Inex Pharmaceuticals Corporation
  • Developer Spectrum Pharmaceuticals
  • Class Antineoplastics; Camptothecins; Small molecules
  • Mechanism of Action DNA topoisomerase I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Ovarian cancer; Small cell lung cancer

Most Recent Events

  • 18 May 2016 No recent reports of development identified - Phase-I for Small cell lung cancer (Late-stage disease, Second-line therapy or greater) in USA (IV)
  • 18 May 2016 No recent reports on development identified - Phase-I for Ovarian cancer (Late-stage disease, Second-line therapy or greater) in USA (IV)
  • 23 Oct 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top